NCT05299099已完成3 期
A Randomized, Open-label, Multi-center Phase III Clinical Trial to Evaluate the Safety and Efficacy of IN-C006 Inj. Compared With RCN301 in Postoperative Patients Requiring Central Parenteral Nutrition
适应症
干预措施
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- Adverse drug reaction rate
研究概览
简要总结
This study is designed to evaluate the safety and efficacy of IN-C006 inj. and RCN301 in postoperative patients requiring central parenteral nutrition.
详细描述
This study is a randomized, open-label, phase 3 design. The subject will be assigned to one of the two treatment groups (IN-C006 inj. or RCN301)
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Supportive Care
- 盲法
- None
入排标准
- 年龄范围
- 19 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age over 19 at the time of obtaining the informed consent form
- •Requiring over 3 days of parenteral nutrition via a central vein after an operation
- •BMI 16 ~ 30 kg/㎡
排除标准
- •Has received parenteral nutrition within 7 days of screening
- •Severe dyslipidemia
- •Uncontrolled diabetes
- •Clinically significant liver disease
- •Clinically significant kidney disease
研究组 & 干预措施
IN-C006 inj.
Experimental
IN-C006 inj. 1970 mL
干预措施: IN-C006 inj. (Drug)
RCN301
Active Comparator
RCN301 1820 mL
干预措施: RCN301 (Drug)
结局指标
主要结局
Adverse drug reaction rate
时间窗: Day 1 to Day 4
Rate of treatment-related adverse events as assessed by CTCAE v5.0 and investigator's evaluation
次要结局
- Change in inflammation parameters(Day 1 to Day 4)
- Change in fatty acid profile(Day 1 to Day 4)
- Incidence of Adverse event(Day 1 to Day 4)
- Normal and abnormal change in physical examination(Day 1 to Day 4)
- Change in laboratory parameters(Day 1 to Day 4)
- Change in vital sign(Day 1 to Day 4)
- Change in nutritional management parameters(Day 1 to Day 4)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
3 期
Clinical Trial to Evaluate the Safety and Efficacy of IN-C006 Peri Inj. Compared With RPN301Parenteral NutritionNCT05337228HK inno.N Corporation59
招募中
3 期
Study of Adjuvant Chemotherapy With or Without PD-1 Inhibitors and Chemoradiotherapy in Resected pN3 Gastric (G) or GEJ AdenocarcinomaGastric CancerNCT04997837Fudan University433
撤回
不适用
External Beam Radiation Therapy Post Surgery in Patients With Lower Extremity Bone Metastases Randomized Efficacy TrialBone MetastasesLower Extremity FracturePathological FractureImpending FractureNCT04109937Sunnybrook Health Sciences Centre
进行中（未招募）
3 期
Post-Surgical Stereotactic Radiotherapy (SRT) Versus GammaTile-ROADS (Radiation One and Done Study)Brain MetastasesNCT04365374GT Medical Technologies, Inc.230
Unknown
3 期
A Clinical Trial of Two Adjuvant Chemotherapy Regimens for Postoperative Gastric CancerStomach NeoplasmsNCT04351867LiNing196